Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFR-Reference-Cited by-同舟云学术

Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFR

Published:2010-03 Issue:2 Volume:18 Page:113-118
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Bhargava Rohit,Beriwal Sushil,Striebel Joan M.,Dabbs David J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference31 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Molecular classification of breast tumors: toward improved diagnostics and treatments;Sorlie;Methods Mol Biol,2007

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

4. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci USA,2003

5. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype;Cheang;Clin Cancer Res,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of Tubule Formation, Indian File Pattern and Apocrine Change With Estrogen and Progesterone Receptors and HER2 Immunostaining;Cureus;2022-10-11

2. Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma;Breast Cancer Research and Treatment;2020-08-08

3. Histopathologic features of breast cancer in Li–Fraumeni syndrome;Modern Pathology;2020-07-07

4. Diverse histomorphology of HER2‐positive breast carcinomas based on differential ER expression;Histopathology;2020-02-03

5. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations;Modern Pathology;2020-01-13